These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 3361129)

  • 41. The effect of platelet-activating factor on IgE binding to, and IgE-dependent biological properties of, human eosinophils.
    Moqbel R; Walsh GM; Nagakura T; MacDonald AJ; Wardlaw AJ; Iikura Y; Kay AB
    Immunology; 1990 Jun; 70(2):251-7. PubMed ID: 2373521
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Possible induction of intercellular adhesion molecule-1 (ICAM-1) expression on endothelial cells by platelet-activating factor (PAF).
    Chihara J; Maruyama I; Yasuba H; Yasukawa A; Yamamoto T; Kurachi D; Mouri T; Seguchi M; Nakajima S
    J Lipid Mediat; 1992; 5(2):159-62. PubMed ID: 1356028
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Receptor expression and functional status of cultured human eosinophils derived from umbilical cord blood mononuclear cells.
    Walsh GM; Hartnell A; Moqbel R; Cromwell O; Nagy L; Bradley B; Furitsu T; Ishizaka T; Kay AB
    Blood; 1990 Jul; 76(1):105-11. PubMed ID: 1973060
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Priming of human eosinophils by platelet-activating factor enhances the number of cells able to bind and respond to opsonized particles.
    Blom M; Tool AT; Roos D; Verhoeven AJ
    J Immunol; 1992 Dec; 149(11):3672-7. PubMed ID: 1431137
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils.
    Wardlaw AJ; Moqbel R; Cromwell O; Kay AB
    J Clin Invest; 1986 Dec; 78(6):1701-6. PubMed ID: 3023451
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Eosinophil activation on biologic surfaces. Production of O2- in response to physiologic soluble stimuli is differentially modulated by extracellular matrix components and endothelial cells.
    Dri P; Cramer R; Spessotto P; Romano M; Patriarca P
    J Immunol; 1991 Jul; 147(2):613-20. PubMed ID: 1712813
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Platelet-activating factor-induced endothelial cell expression of adhesion molecules and modulation of surface glycocalyx, evaluated by electron spectroscopy chemical analysis.
    Silvestro L; Ruikun C; Sommer F; Duc TM; Biancone L; Montrucchio G; Camussi G
    Semin Thromb Hemost; 1994; 20(2):214-22. PubMed ID: 7527938
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of the LFA-1 adhesion glycoprotein in neutrophil adhesion to endothelium and plastic surfaces.
    Forsyth KD; Levinsky RJ
    Clin Exp Immunol; 1989 Feb; 75(2):265-8. PubMed ID: 2649287
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PAF-induced eosinophilic and basophilic differentiation in human hematopoietic precursor cells.
    Saito H; Hayakawa T; Mita H; Akiyama K; Shida T
    J Lipid Mediat; 1992; 5(2):135-7. PubMed ID: 1525354
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A surrogate method for assessment of beta(2)-integrin-dependent adhesion of human eosinophils to ICAM-1.
    Zhu X; Subbaraman R; Sano H; Jacobs B; Sano A; Boetticher E; Muñoz NM; Leff AR
    J Immunol Methods; 2000 Jun; 240(1-2):157-64. PubMed ID: 10854610
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased sensitivity of the chemoattractant-induced chemiluminescence in eosinophils isolated from atopic individuals.
    Koenderman L; Bruijnzeel PL
    Immunology; 1989 Aug; 67(4):534-6. PubMed ID: 2767711
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of platelet-activating factor synthesized by normal and granulocyte-macrophage colony-stimulating factor-primed human eosinophils.
    Triggiani M; Schleimer RP; Tomioka K; Hubbard WC; Chilton FH
    Immunology; 1992 Dec; 77(4):500-4. PubMed ID: 1493922
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Integrin alpha 4 beta 7 mediates human eosinophil interaction with MAdCAM-1, VCAM-1 and fibronectin.
    Walsh GM; Symon FA; Lazarovils AL; Wardlaw AJ
    Immunology; 1996 Sep; 89(1):112-9. PubMed ID: 8911148
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human endothelial cells prolong eosinophil survival. Regulation by cytokines and glucocorticoids.
    Lamas AM; Marcotte GV; Schleimer RP
    J Immunol; 1989 Jun; 142(11):3978-84. PubMed ID: 2654295
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Eosinophil penetration through cultured human airway epithelial cell layer.
    Masuda T; Yamaya M; Shimura S; Hoshi H; Sasaki H; Shirato K
    Am J Respir Cell Mol Biol; 1995 Jun; 12(6):633-41. PubMed ID: 7766427
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased biosynthesis of platelet-activating factor in activated human eosinophils.
    Lee T; Lenihan DJ; Malone B; Roddy LL; Wasserman SI
    J Biol Chem; 1984 May; 259(9):5526-30. PubMed ID: 6425292
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Eosinophils isolated by magnetic cell sorting respond poorly to lipid chemoattractants.
    Casale TB; Erger RA; Rozell MD
    Ann Allergy Asthma Immunol; 1999 Aug; 83(2):127-31. PubMed ID: 10480585
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adhesion to fibronectin primes eosinophils via alpha 4 beta 1 (VLA-4).
    Anwar AR; Walsh GM; Cromwell O; Kay AB; Wardlaw AJ
    Immunology; 1994 Jun; 82(2):222-8. PubMed ID: 7927493
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Augmentation of stimulated eosinophil degranulation by VLA-4 (CD49d)-mediated adhesion to fibronectin.
    Neeley SP; Hamann KJ; Dowling TL; McAllister KT; White SR; Leff AR
    Am J Respir Cell Mol Biol; 1994 Aug; 11(2):206-13. PubMed ID: 8049081
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Blood transfusion and the two-insult model of post-injury multiple organ failure.
    Aiboshi J; Moore EE; Ciesla DJ; Silliman CC
    Shock; 2001 Apr; 15(4):302-6. PubMed ID: 11303730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.